Skip to main content
. 2022 Apr 21;19(6):331–343. doi: 10.1038/s41585-022-00580-7

Fig. 1. Genetic evaluation process for patients with or at risk of developing prostate cancer.

Fig. 1

The process and elements involved in pre-test counselling and informed consent, genetic testing and post-test disclosure. Special considerations in each step in the process and unique clinical and psychosocial concerns that can influence decision-making are shown. ADT, androgen-deprivation therapy; GINA, Genetic Information Nondiscrimination Act; VUS, variants of uncertain significance.